Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PROGENICS PHARMACEUTICALS IN Financial Overview

  • Income Statement: PGNX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 67.67 M 75.65 M -7.98 M -11.78%
    Gross Profit 63.06 M 72.62 M -9.56 M -15.15%
    Net Income Before Extra Items/Preferred Div -44.67 M -43.69 M -984,000.00 2.20%
    Operating Income -50.91 M -51.46 M 551,000.00 -1.08%
  • Cash Flow: PGNX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 3.71 M 64.88 M -61.17 M -1,647.95%
    Net Cash Flow - Investing -70.36 M 27.36 M -97.71 M 138.88%
    Net Cash Flow/Operating Activities -28.30 M -39.05 M 10.75 M -37.97%
  • Balance Sheet: PGNX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 157.83 M 189.54 M -31.71 M -20.09%
    Total Liabilities 38.46 M 42.04 M -3.58 M -9.30%
    Shareholders Equity 119.37 M 147.50 M -28.13 M -23.57%
  • Key Ratios / Statistics: PGNX

    • Valuation

      Price/Earnings (TTM) -6.83
      Price/Sales (TTM) 4.52
      Price/Book (MRQ) 1.39
      Price/Cash Flow (TTM) -5.03
    • Profitability

      Gross Margin 93.19
      Operating Margin -75.23
      Profit Margin -66.01
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.16
      Current Ratio (MRQ) 7.18
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -32.79
      Return on Assets (TTM) -29.10
      Return on Investments (TTM) -33.48